Respiratory Medicine
Outline
The Department of Respiratory Medicine at 色多多视频 Hospital is the first of its kind in the Hokuriku region. We have 37 hospital beds, including seven in the respiratory care unit (RCU), allowing us to provide prompt care for patients with respiratory diseases such as pneumonia, chronic obstructive pulmonary disease (COPD), and bronchial asthma. Our department also plays a central role in diagnosing and treating sleep apnea syndrome and interstitial pneumonia.
e-mail: respirat@kanazawa-med.ac.jp
Faculty
Professor and Chair
Associate Professor
Senior Assistant Professor
Assistant professor
Assistant professor
Assistant professor
Assistant professor
Clinical fellow
Clinical fellow
Research Achievements
Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Kazuaki Nishiki, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Disease control in patients with non-small cell lung cancer using pemetrexed: Investigating the best treatment strategy, Thorac Cancer. doi;10.1111/1759-7714.15286、2024.
Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Shiro Mizuno、Influencing factors of efficacy and long-term use of amrubicin in patients with small cell lung cancer. Thorac Cancer. 14：1286-1293、2023.
Yutaka Takahara, Ryudai Abe, Nagae Sumito, Takuya Tanaka, Yoko Ishige, Ikuyo Shinomiya, Kouichi Yamamura, Kazuaki Nishiki, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Takua Oikawa. Investigation of response factors for monotherapy with immnune checkpoint inhibitors in non-small cell lung cancer patients with PD-L1 expression <50%. Thorac Cancer、27：2754-2760、2023.
Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Kazuaki Nishiki, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa．Investigation of response of patients with non－small cell lung cancer to docetaxel（plus ramucirumab) therapy in second-line treatment. Thorac Cancer.14：3549-3555、2023.
Koichi Yamamura, Masafumi Nojiri, Kazuaki Nishiki, Ryo Kato, Shohei Shinomiya, Yutaka Takahara, Taku Oikawa, Takeshi Ishizaki, Hirohisa Toga, Shiro Mizuno. Serum Derivatives of Reactive Oxygen Metabolites are Associated with Severity of Chronic Obstructive Pulmonary Disease and Affected by a P53 Gene Polymorphism. International Journal of Chronic Obstructive Pulmonary Disease. 17:1589-1600、2022
External Research Funding
Grant-in-Aid for Scientific Research (C) 2024-2027
Masafumi Nojiri Total amount 3,250,000 ten (Direct amount 2,500,000 yen)